Jul 3, 2025
We are proud to share our latest review article on #PC111, a fully human anti-Fas Ligand monoclonal antibody, and its potential as a disease-modifying therapy for #pemphigus and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (#SJSTEN).This work highlights how...
Jun 27, 2025
A proud milestone for Scinai Immunotherapeutics Ltd. and our partners at PinCell srl. Heartfelt congratulations to Dr. Roberta Lotti of PinCell srl for receiving the “Oscar of Italian Dermatology” from SIDeMaST – Società Italiana di Dermatologia e delle Malattie...
Jun 27, 2025
We’re excited to announce a major milestone: the Italian government has granted regulatory clearance under the Golden Power regulation for our planned acquisition of Pincell S.r.l., a pioneering Italian biotech company. “We are pleased to have received this...
Jun 27, 2025
I’m honored to have received the “Oscar of Italian Dermatology” from the SIDeMaST – Società Italiana di Dermatologia e delle Malattie Sessualmente Trasmesse, in the category of Immunopathology and Cutaneous Allergies! The awarded paper, “Blocking...
May 9, 2025
PC111 for Pemphigus and Stevens-Johnson Syndrome/Toxic Epidermal...
